8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001193125-19-185089
Material agreement · New debt or obligation
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
From the SEC's structured data for this filing
Loading d636978d8k.htm…